Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nanhai G Chen

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Molecular Therapy Oncolytics|December 25, 2023
miR-146a: Overcoming coldness in ovarian cancerYanqi Ye, Nanhai G Chen
Cancers|July 29, 2025
Vaccinia Virus-A Swiss Army Knife Against CancerMarcin Stawowczyk, Yanqi Ye, Nanhai G Chen
Current Opinion in Immunology|March 19, 2018
Oncolytic viruses and immunityShyambabu Chaurasiya, Nanhai G Chen, Yuman Fong
Cancers|April 20, 2018
Oncolytic Virotherapy versus Cancer Stem Cells: A Review of Approaches and MechanismsShyambabu Chaurasiya, Nanhai G Chen, Susanne G Warner
Biomedicines|May 25, 2017
From Benchtop to Bedside: A Review of Oncolytic VirotherapyAudrey H Choi, Michael P O'Leary, Yuman Fong, et al.
Journal of Translational Medicine|August 21, 2012
Oncolytic vaccinia virus GLV-1h68 strain shows enhanced replication in human breast cancer stem-like cells in comparison to breast cancer cellsHuiqiang Wang, Nanhai G Chen, Boris R Minev, et al.
Journal of Translational Medicine|September 29, 2011
Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in miceNanhai G Chen, Yong A Yu, Qian Zhang, et al.
Molecular Therapy Oncolytics|May 14, 2019
Oncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both WorldsVenkatesh Sivanandam, Christopher J LaRocca, Nanhai G Chen, et al.
Advances in Virology|July 4, 2012
Oncolytic virusesNanhai G Chen, Aladar A Szalay, R Mark L Buller, et al.
Journal of Translational Medicine|July 8, 2015
Microglia and astrocytes attenuate the replication of the oncolytic vaccinia virus LIVP 1.1.1 in murine GL261 gliomas by acting as vaccinia virus trapsChristina Kober, Susanne Rohn, Stephanie Weibel, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Molecular Therapy Oncolytics|December 25, 2023
miR-146a: Overcoming coldness in ovarian cancerYanqi Ye, Nanhai G Chen
Cancers|July 29, 2025
Vaccinia Virus-A Swiss Army Knife Against CancerMarcin Stawowczyk, Yanqi Ye, Nanhai G Chen
Current Opinion in Immunology|March 19, 2018
Oncolytic viruses and immunityShyambabu Chaurasiya, Nanhai G Chen, Yuman Fong
Cancers|April 20, 2018
Oncolytic Virotherapy versus Cancer Stem Cells: A Review of Approaches and MechanismsShyambabu Chaurasiya, Nanhai G Chen, Susanne G Warner
Biomedicines|May 25, 2017
From Benchtop to Bedside: A Review of Oncolytic VirotherapyAudrey H Choi, Michael P O'Leary, Yuman Fong, et al.
Journal of Translational Medicine|August 21, 2012
Oncolytic vaccinia virus GLV-1h68 strain shows enhanced replication in human breast cancer stem-like cells in comparison to breast cancer cellsHuiqiang Wang, Nanhai G Chen, Boris R Minev, et al.
Journal of Translational Medicine|September 29, 2011
Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in miceNanhai G Chen, Yong A Yu, Qian Zhang, et al.
Molecular Therapy Oncolytics|May 14, 2019
Oncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both WorldsVenkatesh Sivanandam, Christopher J LaRocca, Nanhai G Chen, et al.
Advances in Virology|July 4, 2012
Oncolytic virusesNanhai G Chen, Aladar A Szalay, R Mark L Buller, et al.
Journal of Translational Medicine|July 8, 2015
Microglia and astrocytes attenuate the replication of the oncolytic vaccinia virus LIVP 1.1.1 in murine GL261 gliomas by acting as vaccinia virus trapsChristina Kober, Susanne Rohn, Stephanie Weibel, et al.
Pageof 6